000 04437nam a22002895i 4500
001 402628
003 ES-MaUEC
005 20240528105915.0
007 cr nn 008mamaa
008 230822s2023 sz | o |||| 0|eng d
020 _a9783031353956
024 7 _a10.1007/978-3-031-35395-6
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aT174.7
_b2023 EB
245 0 0 _aNanovaccinology :
_bClinical Application of Nanostructured Materials Research to Translational Medicine
_cedited by Kaushik Pal
250 _a1st ed. 2023
264 1 _aCham
_bSpringer International Publishing
_c2023
300 _a1 recurso en línea
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
505 0 _aGlobal Nanotechnology research trends and commercialization in Nanomedicine -- Nanomedicine:Insight analysis of emerging biomedical research and developments -- Nanomedicine against therapeutic approach of Vaccinology to fight against SARS/COVID-19 -- Nanotechnology offers new vistas: An engineering of vaccine formulation of medical trials -- Nanoparticle as effective tool for the diagnosis of diseases and Vaccinology -- Nanovaccines chemistry of bioconjugation: Antiviral therapeutics for combating viral pandemic -- Functional metal oxide nanoparticles avenue for Nanomedicinal research -- Recent advancement of nanostructured materials for clinical challenges in Vaccinology -- Benefits of molecular medicine from self-assembled nanostructured materials -- Nanoparticles activities of Nanovaccinology: Current opportunities and limitations -- Nanoparticles function as delivery system or immune potentiation -- Vaccines against respiratory viruses and gene therapy applications -- Green nanotechnology revolution in biomedical application and treatments -- Drug delivery and therapeutics for the treatment of infectious diseases -- Biodegradable polymeric nanoparticle-based vaccine adjuvants -- Translational Nanomedicine insights from Vaccinology -- Gold nanoparticles preparation for antibodies and optimizations against infections -- Applied polymeric nanomaterials for drug delivery in the field of medicine -- Flexibility in the design of Nanomedicine using biomimetic immunomodulatory material -- Scopes and opportunities for actively targeted nanoparticle vaccines -- Concluding remarks on target Nanomedicine: Present and future.
520 _aThis book provides an overview of the cumulative work on a driving force for innovation in medicine and modern healthcare, boosting advances in therapeutics, biosensors, vaccines, and clinical systems. The work presented shows how nanoparticles have been investigated as vaccine adjuvants because they possess chemical and structural properties that improve immunogenicity as well as the use of nanotechnology in the construction of immunization systems that has developed into the field of viral nanovaccinology. The volume highlights potential areas of research, innovation, and development of finished products for future commercialization and significant research exploration through nanoparticles that prove capable of surmounting most of the barriers like toxicity issues, clearance from biological system, DNA instability, and differences in expression systems. The contributing authors review the primary literature on principles, limitations, and recent breakthroughs innanoparticle-based antigen delivery vehicles, their use in different diseases, the major bottlenecks, and related issues. Highlighting advances in nanoparticle engineering and the understanding of nanoparticle characteristics as well as critical legacy work dome in the field of nanobiotechnology, the book is ideal for a range of researchers and students in the pure and applied sciences devoted to nanomaterials, vaccinology, and translational medicine. Explains unique trends of novel nanoparticles design, processing, and characterization for emerging nanovaccinology; Presents improvements of biosensors to prevent the need for multiple administrations of the vaccines; Discusses highly efficient and nontoxic vaccines to prevent virus infections.
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-031-35395-6
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
988 _aSpringer_Medicine_2023
999 _c402628
_d402628